View ORCID ProfileReed AC Siemieniuk methodologist, internist,
Jessica J Bartoszko methodologist,
Juan Pablo Díaz Martinez statistician,
Elena Kum graduate student,
Anila Qasim methodologist,
Dena Zeraatkar methodologist et al
Siemieniuk R A, Bartoszko J J, DÃaz Martinez J P, Kum E, Qasim A, Zeraatkar D et al.
Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis
BMJ 2021; 374 :n2231
doi:10.1136/bmj.n2231
Sytstematicaly disregarded: imunocompromised kids + adolescents with hematologic dis., e.g.
Dear Editor,
An antibody therapy requires pre-procedures and a lot of reconvalescent serum. Nevertheless, there certainly is a small group of adults with immunodeficiencies, and a large collective of young people suffering from hematologic diseases who will profit a lot, more than from any other effort of coping with an infectious disease, especially CoViD19 variant D.
Competing interests: No competing interests